CLINICAL TRIALS

DOWNLOAD AGENDA

 

Clinical trials, Tuesday 19 March 2019

08:45

Organiser’s welcome Remarks

Opening Keynote Plenary

David Lane
09:00

Going global and keeping it local: Is biotech innovation sustainable in Asia?

In this keynote presentation, Sir David Lane, one of the key scientists credited on the discovery of cancer gene p53, a gene which mutation cause near 50% of all human cancer, will share his view on how biomedical sciences have developed in Singapore, Japan and the remaining APAC region, and prospects for Asian biotech and pharma industry.
Byung-Geon (BG) Rhee
09:20

Looking east: Integrating Asia into the global era of innovative medicine

Panel discussion
09:40

Pharma 4.0: Women health & Femtech as the next focus

Women’s health goes beyond mother & childcare. For instance, women has a higher risk of cardiovascular diseases compared to men, hence there is a need to invest more on addressing the biological differences in mainstream disease studies to ensure a more effective, personalised treatment. In addition, big data & AI application on female subjects may also differ from male subjects, prompting a need to investigate how studies should be developed differently in the future. This panel brings experts to debate and discuss how femtech is shaping to be the next global pharma focus and the new areas of focus in women's healthcare.
10:20

Speed networking & Networking Refreshment

CLINICAL QUALITY ASSURANCE

Clinical trials
11:15

Chair's opening remarks

Jing Ping Yeo
Clinical trials
11:20

A provider’s perspective in ensuring clinical trial quality

  • Suggestions in promoting collaboration required between pharma, CRO and providers to promote trial efficiency
  • Educational efforts and processes preparation required to ensure trials quality
  • Case study sharing
Seong-Choon Choe
Clinical trials
11:40

Personalised risk assessment in clinical management

  • Disease management and specific screening for better risk assessment
  • Targeted screening and clinical management of specific disease profile
  • Product strategy and clinical development plan in establishing oncology pipelines
Clinical trials
12:00

Reserved for sponsor

Contact Jon at jonathan.mottram@terrapinn.com or +65 6322 2738 to speak at this session.
Panel discussion
Clinical trials
12:20

New considerations in ensuring trials efficiency and transparency (to be confirmed)

This presentation shares insights from Asia, EMA and FDA inspections with case studies on biosimilar trials. It will also discuss the influence of the nature of company on site monitoring activities
Hyejin Shin, Director, Group Leader, Clinical QA, Samsung Bioepis
12:40

Exhibition Visit & Networking Lunch

CLINICAL DESIGN

Clinical trials
14:10

Chair’s opening remarks

Anil Pareek
Clinical trials
14:20

Clinical research as tools in driving innovation

Yongho Oh
Clinical trials
14:40

Improving clinical trials with better stakeholder management

Sophie Tsou
Clinical trials
15:00

Biostatistics perspective in cross country clinical design

Fiona Wong
Clinical trials
15:20

Paediatric subject recruitment: A cross industry case study & future trend

15:40

Exhibition Visit & Networking Refreshments

DIGITAL TRIALS

Mohd Fazli Shuib
Clinical trials
16:40

Leveraging digital platforms and Electronic Medical Record (EMR) to improve patient experience and clinical trials subject recruitment

Lynne Baxter
Clinical trials
17:00

Innovating clinical trials with digital platforms: A cross industry case study

Clinical trials
17:20

Medtech? AI? Big Data? What’s next in enabling more personalised patient care

17:40

Networking Cocktail & End of Conference Day 1

last published: 26/Sep/18 03:35

Clinical trials, Wednesday 20 March 2019

08:45

Organiser’s welcome Remarks

08:50

Chairman’s opening Remarks

09:00

The path to personalised medicine: Key developments

Everyone knows the potential benefits of personalised medicine, but how do we get there? Finding and better defining disease through biomarkers and more accurate diagnostics. Targeted therapeutics to leverage new and emerging diagnostic capabilities. Personalized Medicine to Real-Time Medicine. How to drive success across industry and clinical implementation in an economic manner. This presentation discusses various strategies and key considerations to drive the symbiosis between academia, industry and clinical medicine to drive vastly improved patient outcomes.
Nadia Suttikulpanich
09:20

Disrupt before being disrupted: Using digital tech to connect to previously uneconomic chronic disease customers

10:20

Roundtable discussion

Table 1 Working with clinical outsourcing partners: Risk management and prevention

Table 2 Fostering commercial partnerships to tap on emerging APAC markets

Table 3 Regulatory collaboration and opportunities in more efficient drug development

Table 4 Strategies in making drugs more affordable and accessible to patients in developing countries

Table 5 Universal healthcare- Is it really costly?

Table 6 A convergent approach: Tapping on western expertise to serve Asia population

Table 7 Precision to personalised medicine- How do we get there?

Table 8 Leveraging blockchain technology in making clinical trials more transparent and efficient

Table 9: Data Science in practice: How can sales reps and MSLs use Big Data?

Table 10: The Singapore biotech ecosystem – What comes after the Inflexion?

11:00

Exhibition Visit & Networking Refreshments

CLINICAL DEVELOPMENT

Seokjoong Kim
Clinical trials
11:40

Gearing up for a clinic with CRISPR technology: New strategies

Judith Walker
Clinical trials
12:00

Transitioning from an US food to an Asian drug company: A case study in clinical development

Liping Liu
Clinical trials
12:20

East meets west, the quest to cure

Panel discussion
Clinical trials
12:40

Country showcase: Emerging destinations in Asia Pacific for successful Global Clinical Trials

How to decide when it comes to selecting the ideal trial site for Asia market? This panel is participated by country representatives from Asia Pacific to share with you challenges, opportunities, processes involved in making you pan-Asia study a success
13:00

Exhibition Visit & Networking Lunch

MULTI REGIONAL CLINICAL TRIALS (MRCT)

I-Ning Tang
Clinical trials
14:30

Clinical trial capacity related to MRCT in Taiwan

Salah Uddin
Clinical trials
14:50

GCP and safety guidelines for biosimilars products

Clinical trials
15:10

Reserved for sponsor

Contact Jon at jonathan.mottram@terrapinn.com or +65 6322 2738 to speak at this session.
Panel discussion
Clinical trials
15:50

MRCT in Southern and Southeast Asia: Implications & opportunities

  • Accounting regional differences in stepwise expansions
  • Selection of suitable geographical regions
  • How do South East Asia companies tap on MRCT opportunities in their near future strategies
16:30

End of Phar-East 2019

last published: 26/Sep/18 03:35

 

 

DOWNLOAD PROSPECTUS

 

 

For speaking, sponsorship and exhibition opportunities contact jonathan.mottram@terrapinn.com
Tel: +65 6322 2738